A video on the identified side-effects of the 2 COVID-19 vaccines, Covishield and Covaxin, rolled out in India
Covaxin and Covishield have been rolled out on January 16 throughout India to vaccinate three crore healthcare and frontline staff within the first section of the vaccination drive.
Covaxin is produced below a collaboration between Bharat Biotech and the Indian Council of Medical Research.
Covishield has been developed by AstraZeneca and Oxford University with the Serum Institute of India manufacturing the vaccine for India and low- and middle-income international locations.
Both the vaccines will probably be administered in two doses.